Sunday, November 15, 2026
Source trace. Via News points to the documents behind its reporting and shows what we drew from each, so you can check any claim. How we source
Source document· February 3, 2026

Brandon Hall Group Prepared to Host 2026 HCM Excellence Conference Next Week

View original at globenewswire.com
Brandon Hall Group Prepared to Host 2026 HCM Excellence Conference Next Week West Palm Beach, FL, Feb. 03, 2026 (GLOBE NEWSWIRE) -- Brandon Hall Group™ is prepared to host the 2026 HCM Excellence Conference next week, February 9-12, 2026, at the Hilton West Palm Beach…
Opening lines of the source · short snapshot: read the full document at the original

What we drew from this source

The claims Via News extracted from this document. We point to the source; we don't replace it.

  • Something fundamental has shifted since the conference last year - the uncertainty and ambiguity around AI and transformation is now fading, and organizations have enough clarity to move with purpose instead of hesitation

    80% confidence
  • Distinct layers of readiness have fully emerged in AI adoption, and early pioneers are now showing tangible outcomes, creating a visible roadmap others can follow

    80% confidence
  • Brandon Hall Group has empowered over 10,000,000 professionals globally through its innovative blend of research, learning, and advisory services

    80% confidence
  • 2026 is the time where everyone can level up with AI because the path forward is clearer and proven, and the real opportunity is about accelerating along the maturity curve with intent, confidence and evidence rather than discovering AI

    80% confidence

Cited in these Via News reports

What we know · the intelligence behind this page
Live from the substrate
What we're seeing
Q4 2026 Biotech Catalyst Cluster: Late-Stage Data and PDUFA Dates Converge
Early-to-mid November 2026 is a dense run of clinical readouts and Q3 earnings at AHA, AASLD, ACR and ASH. Mid-cap biotechs (Vir, Mineralys, Arrowhead, Oryzon, Novartis, J&J) are reporting data that feeds into regulatory decisions. The next ones are the ivonescimab BLA (Nov 14) and the lorundrostat PDUFA (Dec 22), followed by ECLIPSE 2/3 and Maritime-1 readouts in Q1 2027. The list also includes an unrelated delisting track (EGM Nov 19, application Jan 25, 2027), and the facts have no AI or fintech content.
Our read on the data ›
Signals we're tracking
Satellite-Terrestrial Network Integration Acceleration
Increased investment and launches in hybrid satellite-cellular networks across telecom industry; competitive responses from other carriers; regulatory activity around satellite spectrum; expansion of emergency/rural connectivity use cases
Patterns we're watching ›
Where sources disagree
Conflicts between sources are checked by an editor before we publish them here.
We flag conflicts openly ›
Recently verified
✓ Checked against the original source
4,959
facts traced to their source, and we flag the ones that don't hold up.
101 entities tracked4,959 facts checked against source5,585 source documents archived
Query this data → isubstrate.com

Working data, not the finished story. This is what our AI has read and extracted from source documents so far. How we source

Brandon Hall Group Prepared to Host 2026 HCM Excellence Conference Next Week: Source | Via News | finance.via.news